期刊文献+

胃癌组织中EGFR、C-erbB-2、TopoⅡα及P-gp的表达及意义 被引量:8

Expressions and significance of EGFR,C-erbB-2,TopoⅡα and P-gp in human gastric cancer tissues
下载PDF
导出
摘要 目的:探讨胃癌组织中表皮生长因子受体(EGFR)、人类表皮生长因子受体2(C-erbB-2)、拓扑异构酶Ⅱα(TopoⅡα)和P-糖蛋白(P-gp)的表达及其与临床病理特征的关系。方法:应用免疫组化SP法检测130例胃癌组织中EGFR、C-erbB-2、TopoⅡα和P-gp的表达情况,并结合临床病理特点进行分析。结果:EGFR、C-erbB-2、TopoⅡα和P-gp在胃癌组织中的阳性表达率依次为87.7%(114/130)、53.8%(70/130)、50%(65/130)和33.8%(44/130)。EGFR、C-erbB-2、P-gp在高、中分化胃癌中的阳性表达率明显高于低分化胃癌(P<0.05);C-erbB-2在直径<5cm的胃癌(胃体、胃窦部和幽门部,Ⅲ期和Ⅳ期胃癌)中的阳性表达率明显高于直径≥5cm的胃癌(贲门部及I期和Ⅱ期胃癌),(P<0.05);EGFR在贲门和胃体部胃癌的阳性表达率明显高于胃窦及幽门部胃癌(P<0.05);TopoⅡα在有淋巴结转移的胃癌中表达率明显低于无淋巴结转移的胃癌(P<0.05)。胃癌组织中EGFR和TopoⅡα的表达呈正相关(P<0.05)。结论:EGFR、C-erbB-2、TopoⅡα及P-gp参与胃癌的生长、侵袭和转移过程。它们的联合检测可作为判断胃癌预后、筛选高危转移患者的有效指标,同时也对胃癌的靶向药物治疗有指导意义。 Objective:To detect the expressions of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor - 2 ( C - erbB - 2 ), Topo IIα and P - gp in gastric cancer tissues, and to analyze the relationship among them and the clinicopathologic factors of gastric cancer. Methods:The SP immunohistochemical stain was used to detect EGFR, C -erbB- 2, Topo IIα and P -gp protein expressions in sample of 130 gastric cancer tissues . And their corresponding clinical data were analyzed retrospectively. Results:The expression rates of E GFR, C - erbB -2, Topo IIα and P - gp protein in gastric cancer tissue were 87.7 % (114/130) ,53.8 % (70/130) ,50% (65/130) and 33.8% (44/130). EGFR, C- erbB- 2, P-gp expressions were obviously higher in high and middle differentiation gastric carcinoma than in poorly differentiated gastric carcinoma ( P 〈 0. 05 ) ; An obvious increasing tendency as tumour's diameter 〈5cm,tumor in corpus ventriculi or in sinus ventriculi and pylorus,tomour in stage and IVstage were Showed by the positive expression rates of C - erbB -2 (P 〈0. 05 ). EGFR Ⅲ expression was obviously high in gastric cardia and corpus ventriculi than in sinus ventriculi and pylorus in gastric carcinoma ( P 〈 0.05 ) ; Topot expression was correlated with lymphatic metastasis occurred( P 〈 0.05 ). There was a stable positive correlation between EGFR and Topo ]] ~x expressions in gastric cancer tissue (P 〈 0.05 ). Conclusion: EGFR, C - erbB - 2, Topo I1 ct and P - gp expressions participate the development,invasion and metastasis process of gastric cancer. Combined detection of them can be lookeff as an important symbol for judging the prognosis of gastric cancer and screening the high - risk metastasis patients, and guiding the molecular targeting therapy of gastric cancer.
出处 《现代肿瘤医学》 CAS 2013年第4期834-837,共4页 Journal of Modern Oncology
关键词 胃癌 表皮生长因子受体 人类表皮生长因子受体2 拓扑异构酶Ⅱα P-糖蛋白 免疫组织化学 gastric cancer EGFR C - erbB - 2 Topo IIα P, gp immunohistochemistry
  • 相关文献

参考文献13

  • 1Bang Y.I, Van Cutsem E, Feyereislova A, et al. Trastuzumab in com- bination with chemotherapy versus chemotherapy alone for treat- ment of HER2 - positive advanced gastric or gastro - oesophageal junction cancer (TOGA) : a phase 3, open - label, randomised con- trolled trial [ J ]. Lancet,2010,376 (9742) :687 - 697.
  • 2Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers[ J]. Int J Cancer, 2006,118(2) :257 -262.
  • 3Tamas P, Solti Z, Bauer P, et al. Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac [ J ]. J Biol Chem, 2003,278 ( 7 ) : 5163 - 5171.
  • 4Lordick F, Luber B, Lorenzen S, et al. Cetuximab plus oxaliplatin / leucovorin/5 - fluorouracil in first - line metastatic gastric cancer: a phase Ⅱ study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) [J]. Br J Cancer,2010,102 (3) :500 -505.
  • 5Okamoto I. Epidermal growth factor receptor in relation to tumor de- velopment EGFR - targeted anticancer therapy[ J]. FEBS J,2010, 277(2) :309 -315.
  • 6Goueli BS, Janknecht R. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2 / Neu, Ras, or Raf[ J ]. Mol Cell Biol,2004,24 ( 1 ) :25 - 35.
  • 7Finkenzeller G, Weindel K, Zimmermann W, et al. Activated Neu / ErbB -2 induces expression of the vascular endothelial growth fac- tor gene by functional activation of the transcription factor Spl [ J]. Angiogenesis ,2004,7 ( 1 ) :59 -68.
  • 8Hsu Jr, Chen TC, Tseng JH, et al. Impact of HER2 overexpression/ amplification on the prognosis of gastric Cancer patients undergoing resection : a single - center study of '1036 patients [ J ]. Oncologist, 2011,16(12) :1706 - 17~3.
  • 9Hohler T, Rtlschoff J, Ridwelski K, et al. HER2 testing and targeted therapy in advanced gastric cancer[ J]. Onkologie,2010,33 ( Suppl 4) :26 -30.
  • 10Heisig P. Type Ⅱ topoisomerases - inhibitors, repair mechanisms and mutations [ J ]. Mutagenesis ,2009,24 (6) :465 - 469.

同被引文献64

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部